{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:08:48Z","timestamp":1789528128817,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jogc.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T11:50:20Z","timestamp":1593604220000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study"],"prefix":"10.1016","volume":"43","author":[{"given":"Am\u00e9lie","family":"Boutin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Gasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"T\u00e9tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2020.06.011_bib0001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2020.06.011_bib0002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jogc.2020.06.011_bib0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogc.2020.06.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2020.06.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0008","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2020.06.011_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.jogc.2020.06.011_bib0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0011","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.08.047","article-title":"Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?","volume":"222","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0012","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.18899","article-title":"Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.jogc.2020.06.011_bib0013","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2020.06.011_bib0014","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.5645","article-title":"Aspirin for prevention of preeclampsia and fetal growth restriction","volume":"40","author":"Loussert","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2020.06.011_bib0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jogc.2017.07.025","article-title":"Maternal characteristics for the prediction of preeclampsia in nulliparous women: the great obstetrical syndromes (GOS) Study","volume":"40","author":"Boutin","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2020.06.011_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.preghy.2019.03.005","article-title":"Prediction models for preeclampsia: a systematic review","volume":"16","author":"De Kat","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jogc.2020.06.011_bib0017","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/AOG.0b013e3182571669","article-title":"First-trimester prediction of preeclampsia in nulliparous women at low risk","volume":"119","author":"Myatt","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0018","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.jogc.2020.06.011_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0020","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3109\/14767058.2014.978758","article-title":"First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness","volume":"28","author":"Moon","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2020.06.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0022","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.06.011_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000487301","article-title":"First-trimester placental growth factor for the prediction of preeclampsia in nulliparous women: the great obstetrical syndromes cohort study","volume":"45","author":"Boutin","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2020.06.011_bib0024","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jogc.2017.08.047","article-title":"Does low PAPP-A predict adverse placenta-mediated outcomes in a low-risk nulliparous population? The great obstetrical syndromes (GOS) study","volume":"40","author":"Boutin","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2020.06.011_bib0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.preghy.2017.11.005","article-title":"First-trimester mean arterial blood pressure and the risk of preeclampsia: The Great Obstetrical Syndromes (GOS) study","volume":"12","author":"Gasse","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jogc.2020.06.011_bib0026","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/14767058.2017.1399117","article-title":"Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study","volume":"32","author":"Gasse","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2020.06.011_bib0027","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2020.06.011_bib0028","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2020.06.011_bib0029","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2020.06.011_bib0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/uog.15818","article-title":"Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks\u2019 gestation in screening for pre-eclampsia","volume":"47","author":"Bredaki","year":"2016","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216320305272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216320305272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:37:40Z","timestamp":1761665860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216320305272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1701216320305272"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2020.06.011","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}